Altamira Therapeutics Ltd. Recorded Big Gain
Tue, Dec 12, 2023 at 07:15 PM
Altamira Therapeutics Ltd. (CYTO:NASDAQ) jumped higher at $0.25, representing a gain of 34%. On Tue, Dec 12, 2023, CYTO:NASDAQ hit a New 2-Week Intraday Low of $0.16. The stock got featured on our News Catalysts scanner on Mon, Dec 11, 2023 at 10:48 AM in the 'INVESTOR UPDATE' category. From Tue, Nov 28, 2023, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Nov 30, 2023 at $0.86 with a volume of 69M+.
About Altamira Therapeutics Ltd. (CYTO:NASDAQ)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 150%
- C4 Therapeutics Inc. (CCCC:NASDAQ), 98.31%
- Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
- Kubient Inc. (KBNT:NASDAQ), 62.5%
- Aditxt Inc. (ADTX:NASDAQ), 60.26%
- Icosavax Inc. (ICVX:NASDAQ), 49.48%
- Chanson International Holding (CHSN:NASDAQ), 36.56%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 35.71%
- Hanryu Holdings, Inc. (HRYU:NASDAQ), 35.05%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 34%